Sebastian Diecke Selected Research

Donnai-Barrow syndrome

8/2021	Corrigendum to Flemming J, Marczenke M, Rudolph I-M, et al. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome. Kidney Int. 2020;98:159-167.
1/2020	Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sebastian Diecke Research Topics

Disease

3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 04/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 09/2015
2	Donnai-Barrow syndrome 08/2021 - 01/2020
2	Cardiac Arrhythmias (Arrythmia) 01/2019 - 04/2013
1	Alcoholism (Alcohol Abuse) 01/2020
1	Hypertrophy 01/2020
1	Epilepsy (Aura) 01/2019
1	Syncope (Fainting) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Glut1 Deficiency Syndrome 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Mesothelioma 01/2018
1	Neoplasms (Cancer) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 05/2017
1	Congenital Heart Defects (Congenital Heart Defect) 05/2017
1	Myocardial Infarction 08/2015
1	Ischemia 08/2015
1	Obesity 04/2015
1	Myocarditis (Carditis) 08/2014
1	Coxsackievirus Infections 08/2014
1	Genomic Instability 06/2013
1	Cardiotoxicity 04/2013
1	Long QT Syndrome 04/2013
1	Heart Diseases (Heart Disease) 04/2013
1	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 04/2013
1	familial dilated cardiomyopathy 04/2013
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 04/2013
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2006

Drug/Important Bio-Agent (IBA)

2	Low Density Lipoprotein Receptor-Related Protein-2IBA 08/2021 - 01/2020
2	LigandsIBA 08/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2018 - 08/2014
1	Serine (L-Serine)FDA Link 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	Sodium Channels (Sodium Channel)IBA 01/2019
1	Carbachol (Carbastat)FDA Link 01/2019
1	CalcineurinIBA 01/2019
1	Lamin Type A (Lamin A)IBA 01/2019
1	Cancer VaccinesIBA 01/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018
1	AntigensIBA 01/2018
1	VaccinesIBA 01/2018
1	Transcription Activator-Like Effector NucleasesIBA 05/2017
1	Biological ProductsIBA 05/2017
1	CytokinesIBA 08/2015
1	Pravastatin (Pravachol)FDA LinkGeneric 04/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2015
1	adenovirus receptorIBA 08/2014
1	Antiviral Agents (Antivirals)IBA 08/2014
1	SirtuinsIBA 06/2013
1	Pharmaceutical PreparationsIBA 04/2013
1	Prion ProteinsIBA 01/2006
1	Glycoproteins (Glycoprotein)IBA 01/2006
1	Protein Isoforms (Isoforms)IBA 01/2006

Therapy/Procedure

3	Therapeutics 01/2016 - 08/2014
1	Immunotherapy 01/2018
1	Transplantation 08/2015
1	Lasers (Laser) 08/2015